21Apr 2022
Advances in exosome therapies in ophthalmology–From bench to clinical trial

Advances in exosome therapies in ophthalmology–From bench to clinical trial

During the last decade, the fields of advanced and personalized therapeutics have constantly been evolving, utilizing novel techniques such as gene editing and RNA therapeutic approaches. Synthetic therapeutic drugs can also be encapsulated into exosomes as they have a hydrophilic core, which makes them suitable to carry water‐soluble drugs. The exosome properties present an added advantage to the targeted delivery of therapeutics, leading to increased efficacy and minimizing the adverse side effects. Exosomes have also demonstrated decreased long‐term accumulation in tissues and organs and thus carry a low risk of systemic toxicity. This review aims to discuss all the advances in exosome therapies in ophthalmology and to give insight into the challenges that would need to be overcome before exosome therapies can be translated into clinical practice.

  • #ophthalmology

Like

Save

Share